Peter Ruef

742 total citations
50 papers, 605 citations indexed

About

Peter Ruef is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Peter Ruef has authored 50 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 10 papers in Epidemiology. Recurrent topics in Peter Ruef's work include Blood properties and coagulation (15 papers), Erythrocyte Function and Pathophysiology (15 papers) and Immune Response and Inflammation (9 papers). Peter Ruef is often cited by papers focused on Blood properties and coagulation (15 papers), Erythrocyte Function and Pathophysiology (15 papers) and Immune Response and Inflammation (9 papers). Peter Ruef collaborates with scholars based in Germany, United States and Qatar. Peter Ruef's co-authors include O Linderkamp, Otwin Linderkamp, O Linderkamp, Johannes Pöschl, Claude Leray, Johannes Poeschl, H. Schmid‐Schönbein, Lutz Koch, David Frommhold and E. P. Zilow and has published in prestigious journals such as Critical Care Medicine, Diabetologia and Annals of Surgical Oncology.

In The Last Decade

Peter Ruef

50 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Ruef Germany 13 225 176 119 118 99 50 605
Alfred A. Santos United States 9 95 0.4× 107 0.6× 175 1.5× 202 1.7× 97 1.0× 9 606
Martin Ploder Austria 12 78 0.3× 189 1.1× 172 1.4× 171 1.4× 158 1.6× 17 916
Zhe Zhou China 13 488 2.2× 104 0.6× 70 0.6× 74 0.6× 207 2.1× 44 805
Yong Wu China 18 146 0.6× 185 1.1× 62 0.5× 124 1.1× 208 2.1× 39 912
Afig Hüseyinov Türkiye 17 123 0.5× 79 0.4× 76 0.6× 77 0.7× 76 0.8× 35 697
D. Vital Durand France 16 109 0.5× 94 0.5× 59 0.5× 43 0.4× 108 1.1× 83 677
Katharina Ruzicka Austria 13 79 0.4× 235 1.3× 180 1.5× 55 0.5× 82 0.8× 15 792
Thyyar M. Ravindranath United States 14 99 0.4× 48 0.3× 190 1.6× 125 1.1× 104 1.1× 45 571
Laurent Ripoll France 9 122 0.5× 94 0.5× 145 1.2× 92 0.8× 169 1.7× 20 506
Tom Huecksteadt United States 14 134 0.6× 133 0.8× 45 0.4× 222 1.9× 232 2.3× 17 882

Countries citing papers authored by Peter Ruef

Since Specialization
Citations

This map shows the geographic impact of Peter Ruef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ruef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ruef more than expected).

Fields of papers citing papers by Peter Ruef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ruef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ruef. The network helps show where Peter Ruef may publish in the future.

Co-authorship network of co-authors of Peter Ruef

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Ruef. A scholar is included among the top collaborators of Peter Ruef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Ruef. Peter Ruef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teufel, Ulrike, Peter Burgard, Jochen Meyburg, et al.. (2019). High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders. Orphanet Journal of Rare Diseases. 14(1). 80–80. 4 indexed citations
2.
Ruef, Peter, et al.. (2015). Determination of whole blood and plasma viscosity in term neonates by flow curve analysis with the LS300 viscometer. Clinical Hemorheology and Microcirculation. 63(1). 3–14. 7 indexed citations
3.
Schneider, Markus, et al.. (2014). Topical treatment with propranolol gel as a supplement to the existing treatment of hemangiomas. World Journal of Pediatrics. 10(4). 313–317. 11 indexed citations
4.
Ruef, Peter, et al.. (2014). Flow behavior of fetal, neonatal and adult RBCs in narrow (3–6 μm) capillaries – Calculation and experimental application. Clinical Hemorheology and Microcirculation. 58(2). 317–331. 2 indexed citations
5.
Böhler, Thomas, Ingo Bruder, Peter Ruef, et al.. (2014). Necrotizing Enterocolitis and Focal Intestinal Perforation in Neonatal Intensive Care Units in the State of Baden-Wurttemberg, Germany. Pediatric Reports. 6(1). 5194–5194. 6 indexed citations
6.
Schneider, Markus, et al.. (2014). A retrospective analysis of systemic propranolol for the treatment of complicated infantile haemangiomas. Acta Paediatrica. 103(9). 977–983. 11 indexed citations
7.
Kunz, Pierre, Jörg Fellenberg, Linda Moskovszky, et al.. (2014). Improved Survival in Osteosarcoma Patients with Atypical Low Vascularization. Annals of Surgical Oncology. 22(2). 489–496. 23 indexed citations
8.
Ruef, Peter, et al.. (2014). Determination of whole blood and plasma viscosity by means of flow curve analysis. General Physiology and Biophysics. 33(3). 285–293. 12 indexed citations
9.
Buschmann, Kirsten, et al.. (2012). CXCL1-Triggered Interaction of LFA1 and ICAM1 Control Glucose-Induced Leukocyte Recruitment during InflammationIn Vivo. Mediators of Inflammation. 2012. 1–12. 12 indexed citations
10.
Ruef, Peter, et al.. (2010). Effects of phosphodiesterase (III/IV)-inhibitors and cytokines on mechanical properties of neutrophilic granulocytes in neonates and adults. Clinical Hemorheology and Microcirculation. 45(2-4). 301–310. 5 indexed citations
11.
Kölker, Stefan, et al.. (2007). Gamma-Hydroxybutyric Acid Sedation in Neonates and Children Undergoing MR Imaging. Klinische Pädiatrie. 219(4). 217–219. 7 indexed citations
12.
Ruef, Peter, et al.. (2005). Deformability of passive and activated neutrophils in children with Gram‐negative septicemia. Scandinavian Journal of Clinical and Laboratory Investigation. 65(4). 333–340. 11 indexed citations
13.
14.
Pöschl, Johannes, et al.. (2003). Six Day Antimicrobial Therapy for Early-onset Group B Streptococcal Infection in Near-term and Term Neonates. Scandinavian Journal of Infectious Diseases. 35(5). 302–305. 2 indexed citations
15.
Pöschl, Johannes, Claude Leray, Peter Ruef, Jean‐Pierre Cazenave, & Otwin Linderkamp. (2003). Endotoxin binding to erythrocyte membrane and erythrocyte deformability in human sepsis and in vitro. Critical Care Medicine. 31(3). 924–928. 61 indexed citations
16.
Pöschl, Johannes, et al.. (2002). Ophthalmia Neonatorum Caused by Group B Streptococcus. Scandinavian Journal of Infectious Diseases. 34(12). 921–922. 3 indexed citations
17.
Linderkamp, Otwin, Peter Ruef, Birgit Brenner, Erich Gulbins, & Florian Läng. (1998). Passive Deformability of Mature, Immature, and Active Neutrophils in Healthy and Septicemic Neonates. Pediatric Research. 44(6). 946–950. 40 indexed citations
18.
Ruef, Peter, et al.. (1996). Group B Streptococcus impairs erythrocyte deformability in neonates more than in adults.. Archives of Disease in Childhood Fetal & Neonatal. 74(3). F187–F190. 7 indexed citations
19.
Ruef, Peter, et al.. (1996). Effects of group‐A streptolysin O on neonatal and adult red blood cell deformability and haemolysis. European Journal of Clinical Investigation. 26(6). 461–464. 3 indexed citations
20.
Böhler, Thomas, Albrecht Leo, Peter Ruef, & O Linderkamp. (1990). 182 INCREASED PLASTIC DEFORMATION AND FRAGILITY OF RED CELL MEMBRANES IN TERM AND PRETERM NEONATES: A POSSIBLE CAUSE OF ACCELERATED RED CELL AGING. Pediatric Research. 28(3). 307–307. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfred A. Santos Breakdown of academic impact, for papers by Martin Ploder Breakdown of academic impact, for papers by Zhe Zhou Breakdown of academic impact, for papers by Yong Wu Breakdown of academic impact, for papers by Afig Hüseyinov Breakdown of academic impact, for papers by D. Vital Durand Breakdown of academic impact, for papers by Katharina Ruzicka Breakdown of academic impact, for papers by Thyyar M. Ravindranath Breakdown of academic impact, for papers by Laurent Ripoll Breakdown of academic impact, for papers by Tom Huecksteadt
Rankless by CCL
2026